# A Prospective Randomized Double-Blinded Placebo Controlled, Explorative Phase I Trial to Investigate the Safety and Tolerability of Two Different Doses of Topically Administered APOSEC™ in Healthy Male Subjects With Artificial Dermal Wounds

> **NCT02284360** · PHASE1 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 10 (estimated)

## Conditions studied

- Healthy
- Artificial Dermal Wound

## Interventions

- **DRUG:** APOSEC™ for cutaneous use

## Key facts

- **NCT ID:** NCT02284360
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2015-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02284360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02284360, "A Prospective Randomized Double-Blinded Placebo Controlled, Explorative Phase I Trial to Investigate the Safety and Tolerability of Two Different Doses of Topically Administered APOSEC™ in Healthy Male Subjects With Artificial Dermal Wounds". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02284360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*